Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJUXV
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,086
Award facts
- Contract value 100% obligated
- $17,085.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,085.68 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen packages. This delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, operates under a firm fixed price structure with no set-aside designation. The award falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. This IDC was established through solicitation SPE2DH-21-R-0002 to procure commercial medical equipment, accessories, consumables, and medical simulation equipment for military healthcare facilities.
Dakota Drug, Inc. has established itself as a critical pharmaceutical supplier to the Defense Logistics Agency, specializing in delivering a comprehensive range of medications and medical supplies to support U.S. Armed Forces medical operations. The company's federal contracting history demonstrates extensive capability across diverse therapeutic categories, including immunological treatments like Cosentyx, supporting the military medical supply chain with reliable, efficient delivery of critical healthcare products to defense facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FJUXV?
SPE2DB25FJUXV was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FJUXV worth?
The government has obligated $17,086 on SPE2DB25FJUXV.
Is contract SPE2DB25FJUXV an order under another contract?
Yes. SPE2DB25FJUXV is a delivery order under SPE2DB24D8003, an indefinite delivery contract.
Was contract SPE2DB25FJUXV competed?
The extent of competition for SPE2DB25FJUXV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award